- psychiatry https://www.mcgill.ca/psychiatry
- med_fac http://www.mcgill.ca/channels
- In the Headlines
- mni https://www.mcgill.ca/channels-contribute
- Medicine Research
- medicine_research https://www.mcgill.ca/medicine
- press_releases https://www.mcgill.ca/newsroom
**The deadline for submissions has been extended to May 22, 2013**
The McGill Department of Psychiatry is calling for submissions for the 2013 McGill Department of Psychiatry Awards. Four awards of $10,000 will be granted this year. The first three awards are granted for proposals pertaining to research related to disorders that affect young people. The fourth is a new award, introduced this year to support fellows at McGill.atry Awards.
Dr. Robert J.
McGill University will confer honorary degrees upon 12 exceptional individuals during this year’s Spring Convocation ceremonies. The recipients – including a world-renowned singer and humanitarian, a Nobel Prize-winning AIDS researcher, a best-selling essayist, a leading philosopher, and business innovators and leaders – will join over 7,300 graduating students taking the stage during Convocation ceremonies from May 27 to June 3.
Convocation ceremonies will be held on McGill’s lower campus, with the exception of the Faculty of Agricultural and Environmental Sciences ceremony (June 3), which will be held at the Macdonald Campus in Sainte-Anne-de-Bellevue.
McGill and ÉTS launch the Quartier de l’innovation, an ecosystem for creativity in the heart of Montreal
Research opens door to new drug therapies for Parkinson’s disease
McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson’s disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and Dr. Kalle Gehring in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin.
McGill University and the Indian Council for Cultural Relations (ICCR) have partnered in the creation of a new chair on India Studies. The agreement was signed recently during a visit to McGill by His Excellency Admiral (Retired) Nirmal Verma, High Commissioner of India to Canada.
Physicians from the McGill University Health Centre (MUHC), McGill University and the University of Calgary have published a review article in the CMAJ (Canadian Medical Association Journal) to help family doctors diagnose and treat fibromyalgia. The article represents the first time researchers have published Canadian guidelines to help manage the condition.
McGill University post-doctoral fellow Spencer Phillips Hey and Prof. Jonathan Kimmelman, Biomedical Ethics, Social Studies of Medicine, Faculty of Medicine argue that some clinical trials of new drugs need to fail in order to protect study volunteers and healthcare systems. Their work is published this week in the journal Science Translational Medicine.
TELUS Health and McGill University have entered into a three-year, million dollar partnership to create a learning environment and conduct research on how best to use technology to improve health and healthcare delivery for Canadians. This joint partnership with McGill is the second for TELUS Health, demonstrating once again that industry and academic communities can collaborate to produce independent, evidence-based research, in order to help address challenges that the Canadian healthcare system is facing.
McGill University announced today its participation in The MasterCard Foundation Scholars Program, a transformative initiative aimed at advancing social and economic progress in Africa. As part of the Program, McGill will receive $27 million over the next decade to educate academically talented young people from economically disadvantaged communities in Africa, and prepare them to return to their home countries, successfully transition into the workforce, and lead change in their communities.
Live 3D images of brain’s vasculature will improve patient diagnosis and treatment
The diagnosis and treatment of potentially life-threatening neurological conditions such as aneurysms and strokes will be significantly improved as a result of cutting-edge technology at the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and the MUHC. The new angiosuite, inaugurated today, offers significant advantages to patients and physicians including most importantly, improved safety and outcomes.
- Creates a 3D “
Researchers from Quebec are big winners in a contest organized by Genome Canada in collaboration with the Canadian Institutes of Health Research (CIHR) after having been awarded 60% of the federal funds granted during this Canada-wide competition aimed at selecting the best genomics and personalized health research projects.